People · Operator
Named in public records as an officer, director or promoter · active 2009–2024 · Pharmaceuticals, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Eyegate Pharmaceuticals Inc | — | Pharmaceuticals | Series A | $72.9M | $92.5M | 2023 |
| UniRisX, LLC | — | Other Technology | Series A | $25.3M | $37.8M | 2009 |
| FINEOS Corp Holdings PLC | — | Other Technology | Series A | $8.3M | $218.3M | 2020 |
David Hollander at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Hollander on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Scott Miller | 1 | 12 |
| Michael Kelly | 1 | 11 |
| John Brennan | 1 | 9 |
| Jonathan Kalman | 1 | 6 |
| Brian Cook | 1 | 5 |
| Praveen Tyle | 1 | 5 |
| Eric Daniels | 1 | 4 |
| Sarah Romano | 1 | 3 |
| Peter Greenleaf | 1 | 3 |
| Thomas E. Hancock | 1 | 3 |
| Steven Boyd | 1 | 3 |
| J. Sebastien Cleiftie | 1 | 2 |
| Brian Strem | 1 | 2 |
| Stephen From | 1 | 2 |
| Paul Chaney | 1 | 2 |
| James Short | 1 | 2 |
| Akhil Tripathi | 1 | 2 |
| Bernard Malfroy-Camine | 1 | 2 |
| Peter Morse | 1 | 2 |
| Keith Maher | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.